Viewing Study NCT04822818


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-01-05 @ 1:27 AM
Study NCT ID: NCT04822818
Status: COMPLETED
Last Update Posted: 2022-12-28
First Post: 2021-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
Sponsor: Assistance Publique - HĂ´pitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module